Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
F. Gerard Moeller, Joy M. Schmitz, Joel L. Steinberg, Charles M. Green, Christopher Reist, Lingo Y. Lai, Alan C. Swann & John Grabowski. (2007) Citalopram Combined with Behavioral Therapy Reduces Cocaine Use: A Double-Blind, Placebo-Controlled Trial. The American Journal of Drug and Alcohol Abuse 33:3, pages 367-378.
Read now
Read now
James Shearer & Linda R Gowing. (2004) Pharmacotherapies for problematic psychostimulant use: a review of current research. Drug and Alcohol Review 23:2, pages 203-211.
Read now
Read now
Hendrée E. Jones, Rolley E. Johnson, George E. Bigelow, Kenneth Silverman, Tim Mudric & Eric C. Strain. (2004) Safety and Efficacy of L-tryptophan and Behavioral Incentives for Treatment of Cocaine Dependence: A Randomized Clinical Trial. American Journal on Addictions 13:5, pages 421-437.
Read now
Read now
Thomas Kosten, Jean Falcioni, Alison Oliveto & Alan Feingold. (2004) Depression Predicts Higher Rates of Heroin Use on Desipramine with Buprenorphine than with Methadone. American Journal on Addictions 13:2, pages 191-201.
Read now
Read now
MelissaP. Piasecki, GerriM. Steinagel, OleJ. Thienhaus & BarbaraS. Kohlenberg. (2002) An Exploratory Study: The Use of Paroxetine for Methamphetamine Craving. Journal of Psychoactive Drugs 34:3, pages 301-304.
Read now
Read now
Aimee L McRae & Kathleen T Brady. (2001) Review of sertraline and its clinical applications in psychiatric disorders. Expert Opinion on Pharmacotherapy 2:5, pages 883-892.
Read now
Read now
Laure Buydens-Branchey, Marc Branchey, Jeffrey Hudson, Michael Rothman, Paul Fergeson & Craig McKernin. (1998) Effect of Fenfluramine Challenge on Cocaine Craving in Addicted Male Users. American Journal on Addictions 7:2, pages 142-155.
Read now
Read now
Stephen J. Donovan & Edward V. Nunes. (1998) Treatment of Comorbid Affective and Substance Use Disorders Therapeutic Potential of Anticonvulsants. American Journal on Addictions 7:3, pages 210-220.
Read now
Read now
Ivan D. Montoya, Kenzie L. Preston, Edward J. Cone, Richard Rothman & David A. Corelick. (1996) Safety and Efficacy of Bupropion Combined with Bromocriptine for Treatment of Cocaine Dependence. American Journal on Addictions 5:1, pages 69-75.
Read now
Read now
Articles from other publishers (57)
N. Pintori, A. Piva, V. Guardiani, C. M. Marzo, I. Decimo & C. Chiamulera. (2022) The interaction between Environmental Enrichment and fluoxetine in inhibiting sucrose-seeking renewal in mice depend on social living condition. Psychopharmacology 239:7, pages 2351-2361.
Crossref
Crossref
Dimy Fluyau, Paroma Mitra, Ankit Jain, Vasanth Kattalai Kailasam & Christopher G. Pierre. (2022) Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis. European Journal of Clinical Pharmacology 78:6, pages 931-942.
Crossref
Crossref
Barry J. Everitt, Chiara Giuliano & David Belin. (2018) Addictive behaviour in experimental animals: prospects for translation. Philosophical Transactions of the Royal Society B: Biological Sciences 373:1742, pages 20170027.
Crossref
Crossref
Maryam Bashiri, Michael J. Mancino, Virginia A. Stanick, Jeff Thostenson, Thomas R. Kosten & Alison H. Oliveto. (2017) Moderators of response to sertraline versus placebo among recently abstinent, cocaine dependent patients: A retrospective analysis of two clinical trials. The American Journal on Addictions 26:8, pages 807-814.
Crossref
Crossref
Christian P. Müller & Judith R. Homberg. (2015) The role of serotonin in drug use and addiction. Behavioural Brain Research 277, pages 146-192.
Crossref
Crossref
Andrew C. McCreary, Christian P. Müller & Małgorzata Filip. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse
41
83
.
Barry J. Everitt. (2014) Neural and psychological mechanisms underlying compulsive drug seeking habits and drug memories – indications for novel treatments of addiction. European Journal of Neuroscience 40:1, pages 2163-2182.
Crossref
Crossref
Kathryn A. Cunningham & Noelle C. Anastasio. (2014) Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology 76, pages 460-478.
Crossref
Crossref
Helen Fox & Rajita Sinha. 2014. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse. Emerging Targets & Therapeutics in the Treatment of Psychostimulant Abuse
217
265
.
Yann Pelloux, Ruth Dilleen, Daina Economidou, David Theobald & Barry J Everitt. (2012) Reduced Forebrain Serotonin Transmission is Causally Involved in the Development of Compulsive Cocaine Seeking in Rats. Neuropsychopharmacology 37:11, pages 2505-2514.
Crossref
Crossref
Alison Oliveto, James Poling, Michael J. Mancino, D. Keith Williams, Jeff Thostenson, Rhonda Pruzinsky, Kishorchandra Gonsai, Mehmet Sofuoglu, Gerardo Gonzalez, Shanti Tripathi & Thomas R. Kosten. (2011) Sertraline delays relapse in recently abstinent cocaine‐dependent patients with depressive symptoms. Addiction 107:1, pages 131-141.
Crossref
Crossref
Donna M. Platt & James K. Rowlett. 2012. Nonhuman Primates in Biomedical Research. Nonhuman Primates in Biomedical Research
817
839
.
Pier Paolo Pani, Emanuela Trogu, Simona Vecchi & Laura Amato. (2011) Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Daryl Shorter & Thomas R Kosten. (2011) Novel pharmacotherapeutic treatments for cocaine addiction. BMC Medicine 9:1.
Crossref
Crossref
HANS O. MELBERG & KEITH HUMPHREYS. (2010) Ineligibility and refusal to participate in randomised trials of treatments for drug dependence. Drug and Alcohol Review 29:2, pages 193-201.
Crossref
Crossref
Mauricio Silva de Lima, Michael Farrell, Anelise ARL Lima Reisser & Bernardo Soares. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
David V. Herin, Craig. R. Rush & John Grabowski. (2010) Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences 1187:1, pages 76-100.
Crossref
Crossref
Christian P. Müller, Martin E. Pum, Gunter Schumann & Joseph P. Huston. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
507
545
.
Catherine G. Sutcliffe, Danielle German, Bangorn Sirirojn, Carl Latkin, Apinun Aramrattana, Susan G. Sherman & David D. Celentano. (2009) Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug and Alcohol Dependence 101:3, pages 146-151.
Crossref
Crossref
E. Ambrosio Flores. (2008) Efectos de la cocaína en el ser humano. Trastornos Adictivos 10:3, pages 151-165.
Crossref
Crossref
Joy M. Schmitz, Marc E. Mooney, F. Gerard Moeller, Angela L. Stotts, Charles Green & John Grabowski. (2008) Levodopa pharmacotherapy for cocaine dependence: Choosing the optimal behavioral therapy platform. Drug and Alcohol Dependence 94:1-3, pages 142-150.
Crossref
Crossref
Antonio Preti. (2007) REVIEW: New developments in the pharmacotherapy of cocaine abuse. Addiction Biology 12:2, pages 133-151.
Crossref
Crossref
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
171
243
.
David Herin & John Grabowski. 2007. Translation of Addictions Science Into Practice. Translation of Addictions Science Into Practice
145
167
.
David McDowell, Edward V. Nunes, Angela M. Seracini, Jami Rothenberg, Suzanne K. Vosburg, Guoguang J. Ma & Eva Petkova. (2005) Desipramine treatment of cocaine-dependent patients with depression: A placebo-controlled trial. Drug and Alcohol Dependence 80:2, pages 209-221.
Crossref
Crossref
Iván D. Montoya, Jennifer R. Schroeder, Kenzie L. Preston, Lino Covi, Annie Umbricht, Carlo Contoreggi, Paul J. Fudala, Rolley E. Johnson & David A. Gorelick. (2005) Influence of psychotherapy attendance on buprenorphine treatment outcome. Journal of Substance Abuse Treatment 28:3, pages 247-254.
Crossref
Crossref
Marta Torrens, Francina Fonseca, Gerard Mateu & Magí Farré. (2005) Efficacy of antidepressants in substance use disorders with and without comorbid depression. Drug and Alcohol Dependence 78:1, pages 1-22.
Crossref
Crossref
Theresa M. Winhusen, Eugene C. Somoza, Judy M. Harrer, Juris P. Mezinskis, Margaret A. Montgomery, R. Jeffrey Goldsmith, Florence S. Coleman, Daniel A. Bloch, Deborah B. Leiderman, Bonita M. Singal, Paul Berger & Ahmed Elkashef. (2005) A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100, pages 68-77.
Crossref
Crossref
Domenic A. Ciraulo, Ofra Sarid-Segal, Clifford M. Knapp, Ann Marie Ciraulo, Joseph LoCastro, Daniel A. Bloch, Margaret A. Montgomery, Deborah B. Leiderman & Ahmed Elkashef. (2005) Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. Addiction 100, pages 12-22.
Crossref
Crossref
Domenic A. Ciraulo, Clifford Knapp, John Rotrosen, Ofra Sarid-Segal, Ann Marie Ciraulo, Joseph LoCastro, David J. Greenblatt & Deborah Leiderman. (2005) Nefazodone treatment of cocaine dependence with comorbid depressive symptoms. Addiction 100, pages 23-31.
Crossref
Crossref
A. R. Lingford-Hughes, S. Welch & D. J. Nutt. (2016) Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 18:3, pages 293-335.
Crossref
Crossref
Kenneth M Carpenter, Adam C Brooks, Suzanne K Vosburg & Edward V Nunes. (2004) The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial. Drug and Alcohol Dependence 74:2, pages 123-134.
Crossref
Crossref
S. Tardieu, Y. Poirier, J. Micallef & O. Blin. (2004) Amphetamine-like stimulant cessation in an abusing patient treated with bupropion. Acta Psychiatrica Scandinavica 109:1, pages 75-78.
Crossref
Crossref
S. Tardieu, Y. Poirier, J. Micallef & O. Blin. (2004) Amphetamine-like stimulant cessation in an abusing patient treated with bupropion. Acta Psychiatrica Scandinavica 109:1, pages 77-78.
Crossref
Crossref
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
139
199
.
Mary E. McCaul & Nancy M. Petry. (2003) The Role of Psychosocial Treatments in Pharmacotherapy for Alcoholism. The American Journal on Addictions 12, pages s41-s52.
Crossref
Crossref
Thomas Kosten, James Poling & Alison Oliveto. (2003) Effects of reducing contingency management values on heroin and cocaine use for buprenorphine‐ and desipramine‐treated patients. Addiction 98:5, pages 665-671.
Crossref
Crossref
Maurício Silva de Lima, Michael Farrell, Anelise ARL Lima Reisser & Bernardo Soares. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Vance W Berger, Azadeh Rezvani & Vanessa A Makarewicz. (2003) Direct effect on validity of response run-in selection in clinical trials. Controlled Clinical Trials 24:2, pages 156-166.
Crossref
Crossref
Maurício Silva de Lima, Bernardo Garcia de Oliveira Soares, Anelise Alves Pereira Reisser & Michael Farrell. (2002) Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97:8, pages 931-949.
Crossref
Crossref
Peter Olausson, Jörgen A. Engel & Bo Söderpalm. (2002) Involvement of serotonin in nicotine dependence: Processes relevant to positive and negative regulation of drug intake. Pharmacology Biochemistry and Behavior 71:4, pages 757-771.
Crossref
Crossref
Joy M Schmitz, Patricia Averill, Angela L Stotts, F.Gerard Moeller, Howard M Rhoades & John Grabowski. (2001) Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug and Alcohol Dependence 63:3, pages 207-214.
Crossref
Crossref
Aimee L. McRae, Kathleen T. Brady & Susan C. Sonne. (2001) ALCOHOL AND SUBSTANCE ABUSE. Medical Clinics of North America 85:3, pages 779-801.
Crossref
Crossref
Nicholas Seivewright, Michael Donmall, Julie Douglas, Tamara Draycott & Tim Millar. (2000) Cocaine misuse treatment in England. International Journal of Drug Policy 11:3, pages 203-215.
Crossref
Crossref
Steven J Robbins, Ronald N Ehrman, Anna Rose Childress, James W Cornish & Charles P O’Brien. (2000) Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug and Alcohol Dependence 59:1, pages 33-42.
Crossref
Crossref
KEVIN A. SEVARINO, ALISON OLIVETO & THOMAS R. KOSTEN. (2006) Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development. Annals of the New York Academy of Sciences 909:1, pages 51-87.
Crossref
Crossref
Philip W. Lavori, Daniel A. Bloch, Peter T. Bridge, Deborah B. Leiderman, Joseph S. LoCastro & Eugene Somoza. (1999) Plans, Designs, and Analyses for Clinical Trials of Anti-Cocaine Medications. Journal of Clinical Psychopharmacology 19:3, pages 246-256.
Crossref
Crossref
Laure Buydens-Branchey, Marc Branchey, Jeffrey Hudson, Michael Rothman, Paul Fergeson & Craig McKernin. (1999) Serotonergic function in cocaine addicts: prolactin responses to sequential d,l-fenfluramine challenges. Biological Psychiatry 45:10, pages 1300-1306.
Crossref
Crossref
THOMAS R. KOSTEN, ATHINA MARKOU & GEORGE F. KOOB. (1998) Depression and Stimulant Dependence. The Journal of Nervous & Mental Disease 186:12, pages 737-745.
Crossref
Crossref
Stephen J. Donovan & Edward V. Nunes. (2010)
Treatment of Comorbid Affective and Substance Use Disorders:
Therapeutic Potential of Anticonvulsants
. The American Journal on Addictions 7:3, pages 210-220.
Crossref
Crossref
Ismene Petrakis, Kathleen M. Carroll, Charla Nich, Lynn Gordon, Thomas Kosten & Bruce Rounsaville. (1998) Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts. Drug and Alcohol Dependence 50:3, pages 221-226.
Crossref
Crossref
Laure Buydens‐Branchey, Marc Branchey, Jeffrey Hudson, Michael Rothman, Paul Fergeson & Craig McKernin. (2010) Effect of Fenfluramine Challenge on Cocaine Craving in Addicted Male Users. The American Journal on Addictions 7:2, pages 142-155.
Crossref
Crossref
Maxine L Stitzer & Sharon L Walsh. (1997) Psychostimulant Abuse: The Case for Combined Behavioral and Pharmacological Treatments. Pharmacology Biochemistry and Behavior 57:3, pages 457-470.
Crossref
Crossref
Henry R. Kranzler, Joseph A. Burleson, Joseph Brown & Thomas F. Babor. (2006) Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive‐Behavioral Therapy in Type B Alcoholics. Alcoholism: Clinical and Experimental Research 20:9, pages 1534-1541.
Crossref
Crossref
Edward V. Nunes, Deborah Deliyannides, Stephen Donovan & Patrick J. McGrath. (1996) THE MANAGEMENT OF TREATMENT RESISTANCE IN DEPRESSED PATIENTS WITH SUBSTANCE USE DISORDERS. Psychiatric Clinics of North America 19:2, pages 311-327.
Crossref
Crossref
Julie K. Staley, Qinjie Ouyang, John Pablo, W. Lee Hearn, Donna D. Flynn, Richard B. Rothman, Kenner C. Rice & Deborah C. Mash. (1996) Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine. Psychopharmacology 127:1-2, pages 10-18.
Crossref
Crossref
Ivan D. Montoya, Kenzie L. Preston, Edward J. Cone, Richard. Rothman & David A. Gorelick. (2010) Safety and Efficacy of Bupropion Combined With Bromocriptine for Treatment of Cocaine Dependence. The American Journal on Addictions 5:1, pages 69-75.
Crossref
Crossref